CCN2 and hepatocellular carcinoma: OPN and BSP are particularly helpful for assessing bone metastases in lung and prostate cancers, whereas other markers such as CTGF, IL-11, and MMP-1 have demonstrated greater prognostic significance in hepatocellular carcinoma (HCC).